UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000030147
Receipt No. R000034432
Official scientific title of the study Modification of Neurotransmission of Brain-Gut Interactions
Date of disclosure of the study information 2018/04/01
Last modified on 2017/11/28 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Modification of Neurotransmission of Brain-Gut Interactions
Title of the study (Brief title) Neuro-modification of Brain-Gut
Region
Japan

Condition
Condition irritable bowel syndrome
healthy controls
Classification by specialty
Medicine in general Gastroenterology Psychosomatic Internal Medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to test our hypothesis that brain-gut interactions in individuals with irritable bowel syndrome (IBS) is different from those in healthy controls.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes brain images of positron emission tomography (PET)
Key secondary outcomes ordinate scale
psychometric tests
plasma/serum hormones

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Placebo
Stratification YES
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 6
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 saline
intravenous administration
one time
Interventions/Control_2 CRH
intravenous administration
one time
Interventions/Control_3 alpha-helical CRH
intravenous administration
one time
Interventions/Control_4 ramosetron
intravenous administration
one time
Interventions/Control_5 naloxone
intravenous administration
one time
Interventions/Control_6 asimadoline
intravenous administration
one time
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Rome III/IV
Asymptomatic healthy individual
Key exclusion criteria organic diseases
psychiatric diseases
Target sample size 240

Research contact person
Name of lead principal investigator Shin Fukudo, MD, PhD
Organization Tohoku University Graduate School of Medicine
Division name Department of Behavioral Medicine
Address 2-1 Seiryo, Aoba, Sendai 980-8575, Japan
TEL 022-717-8162
Email sfukudo@med.tohoku.ac.jp

Public contact
Name of contact person Shin Fukudo, MD, PhD
Organization Tohoku University Graduate School of Medicine
Division name Department of Behavioral Medicine
Address 2-1 Seiryo, Aoba, Sendai 980-8575, Japan
TEL 022-717-8162
Homepage URL
Email sfukudo@med.tohoku.ac.jp

Sponsor
Institute Department of Behavioral Medicine,
Tohoku University Graduate School of Medicine
Institute
Department

Funding Source
Organization JSPS/MEXT
AMED/MHLW
Institutional Grant
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東北大学大学院医学系研究科

Other administrative information
Date of disclosure of the study information
2018 Year 04 Month 01 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2010 Year 05 Month 01 Day
Anticipated trial start date
2010 Year 06 Month 01 Day
Last follow-up date
2022 Year 11 Month 30 Day
Date of closure to data entry
2022 Year 11 Month 30 Day
Date trial data considered complete
2022 Year 11 Month 30 Day
Date analysis concluded
2022 Year 11 Month 30 Day

Related information
URL releasing protocol
Publication of results Partially published
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 11 Month 28 Day
Last modified on
2017 Year 11 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034432